News

Mylan has reported that Matrix Laboratories (Matrix) has received tentative approval from FDA under the President’s Emergency Plan for AIDS Relief (PEPFAR). FDA approved its Abbreviated New Drug

Roche has announced that a phase III study of Avastin (bevacizumab), in combination with a range of chemotherapies, met its primary endpoint. The study met the objective of

Novavax has reported positive preclinical results with its 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. Under a collaborative agreement, the study has been conducted by the scientists

Omnia Biologics (Omnia) and Aparna Biosciences (AparnaBio) has signed a deal for Omnia to provide AparnaBio with process development and production services. Omnia will provide lentiviral vector technical

Light Sciences Oncology (LSO) has reported the first patient dosing in a phase 2 clinical trial of its targeted drug treatment, Aptocine (talaporfin sodium), in benign prostatic hyperplasia

China Pharma has received approval from the Chinese State Food and Drug Administration (SFDA) for the production of generic – Omeprazole Sodium injections. Omeprazole is indicated for the

Sinovac has reported positive top-line results from the completed clinical trial for its H1N1 vaccine. In the study, a total of 1,614 participants over three years old received

Xceleron has signed a second Master Service Agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Xceleron will provide analytical support to GSK and its affiliated research

Strategic Diagnostics (SDI) has bagged US Patent No. 7521201 B2 for using bacteriophages in microbiological assay tests and processes. The invention is a rapid bacterial detection method that